Bottom line
Is XSMO a good fund? The bottom line
XSMO is an index small-cap ETF from Invesco.
It charges 0.35% — about $35 a year on every $10,000 invested, cheaper than 92% of small-cap funds we track.
It returned +9.8% over one year, +9.6% a year over five years, +12.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $3.0 billion in net assets and 110 holdings, its largest position is Invesco Private Prime Fund (11.8%) and the top 10 make up 36.8% of the portfolio.
What stands out
- Low cost: cheaper than 92% of small-cap peers
- 5-year return beat 78% of category peers
What to watch
- High turnover (121% a year) can mean more taxable distributions
Updated Nov 19, 2026
What XSMO invests in
The Invesco S&P SmallCap Momentum ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Momentum Index (the Underlying Index).
The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (S&P DJI or the Index Provider) compiles, maintains and calculates the Underlying Index, which is composed of constituents of the S&P SmallCap 600 Index (the Parent Index) that have the highest momentum score. In general, momentum is the tendency of an investment to exhibit persistence in its relative performance; a momentum style of investing emphasizes investing in securities that have had better recent performance compared to other securities. The momentum score for each security included in the Underlying Index is based on upward price movements of the security as compared to other eligible securities within the Parent Index. In selecting constituent securities for the Underlying Index, the Index…
From the fund's prospectus (filed Aug 27, 2026).
XSMO performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| XSMO | +9.8% | +9.6% | +12.3% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What XSMO costs
On a $10,000 investment, XSMO's 0.35% expense ratio costs about $35 a year. The prospectus estimates $444 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
XSMO top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Invesco Private Prime Fund | 11.81% |
| 2 | Viasat, Inc. | 4.59% |
| 3 | Invesco Private Government Fund | 4.51% |
| 4 | ESCO Technologies Inc. | 2.97% |
| 5 | Protagonist Therapeutics, Inc. | 2.57% |
| 6 | Indivior Pharmaceuticals, Inc. | 2.20% |
| 7 | Mercury Systems, Inc. | 2.17% |
| 8 | StoneX Group Inc. | 2.17% |
| 9 | FormFactor, Inc. | 1.98% |
| 10 | Ligand Pharmaceuticals Inc. | 1.88% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 36.8% of the fund. See all top 25 holdings and asset mix →